These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. de Wet NT, Bester AJ, Viljoen JJ, Filho F, Suleiman JM, Ticona E, Llanos EA, Fisco C, Lau W, Buell D. Aliment Pharmacol Ther; 2005 Apr 01; 21(7):899-907. PubMed ID: 15801925 [Abstract] [Full Text] [Related]
11. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, Bunin N, Wall DA, Hiemenz JW, Satoi Y, Lee JM, Walsh TJ, National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis; 2004 Nov 15; 39(10):1407-16. PubMed ID: 15546073 [Abstract] [Full Text] [Related]
12. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits. Hiraoka T, Kaji Y, Wakabayashi T, Nanbu PN, Okamoto F, Oshika T. Cornea; 2007 Apr 15; 26(3):336-42. PubMed ID: 17413962 [Abstract] [Full Text] [Related]
14. Fluconazole compared with itraconazole in the treatment of esophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study. Barbaro G, Barbarini G, Di Lorenzo G. Scand J Infect Dis; 1995 Apr 15; 27(6):613-7. PubMed ID: 8685642 [Abstract] [Full Text] [Related]
15. Micafungin (Mycamine) for fungal infections. Med Lett Drugs Ther; 2005 Jun 20; 47(1211):51-2. PubMed ID: 15961968 [Abstract] [Full Text] [Related]
17. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Ally R, Schürmann D, Kreisel W, Carosi G, Aguirrebengoa K, Dupont B, Hodges M, Troke P, Romero AJ, Esophageal Candidiasis Study Group. Clin Infect Dis; 2001 Nov 01; 33(9):1447-54. PubMed ID: 11577374 [Abstract] [Full Text] [Related]
18. Cost-effectiveness analysis of antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. Schonfeld W, Wang Cheng J, Tong KB, Seifeldin R. Clin Ther; 2008 May 01; 30(5):964-73. PubMed ID: 18555943 [Abstract] [Full Text] [Related]
19. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Queiroz-Telles F, Berezin E, Leverger G, Freire A, van der Vyver A, Chotpitayasunondh T, Konja J, Diekmann-Berndt H, Koblinger S, Groll AH, Arrieta A, Micafungin Invasive Candidiasis Study Group. Pediatr Infect Dis J; 2008 Sep 01; 27(9):820-6. PubMed ID: 18679151 [Abstract] [Full Text] [Related]
20. Micafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans. Bland CM, Thomas S. Ann Pharmacother; 2009 Mar 01; 43(3):528-31. PubMed ID: 19261955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]